Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001522897-11-000002
Filing Date
2011-06-09
Accepted
2011-06-09 15:19:37
Documents
1
Effectiveness Date
2011-06-09
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8147
  Complete submission text file 0001522897-11-000002.txt   9206
Mailing Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116 617-482-2333
Karuna Pharmaceuticals Inc (Filer) CIK: 0001522897 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-161041 | Film No.: 11903091